|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$1,458
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$4,009
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$4,680
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$51,480
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Viruses and Cancer
|
5T32CA060395-22
|
$156,724
|
$39,181
|
MEYERS, CRAIG
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
Viral Oncology Training Grant
|
5T32CA009111-40
|
$391,340
|
$117,402
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$321,309
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$17,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$9,536
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$5,300
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$2,224
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$2,842
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$438,793
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Unmasking the roles of KSHV glycoproteins in virus entry and vaccine development
|
5K01CA184388-05
|
$98,360
|
$49,180
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S1
|
$247,355
|
$2,474
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S2
|
$35,000
|
$350
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S3
|
$124,862
|
$1,249
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S4
|
$48,726
|
$487
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S5
|
$174,039
|
$1,740
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S6
|
$107,460
|
$1,075
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
University of Virginia Cancer Center Support Grant
|
5P30CA044579-27
|
$2,599,349
|
$25,993
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
UM CFAR SCCC Argentina Consortium for research and training in Virally Induced AIDS Malignancies
|
5U54CA221208-02
|
$670,069
|
$314,932
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Training in Tumor Virology
|
5T32CA115299-12
|
$319,088
|
$127,635
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
The Zambia AIDS Malignancies Diagnosis and Pathogenesis Program (ZAMDAPP)
|
5U54CA221204-02
|
$673,579
|
$114,508
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
The Role of Viral and Cellular miRNAs in B-cell Lymphomagenesis
|
5R00CA175181-05
|
$219,120
|
$219,120
|
SKALSKY, REBECCA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-24
|
$6,420,169
|
$192,605
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S1
|
$250,000
|
$7,500
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S2
|
$200,000
|
$6,000
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S3
|
$246,169
|
$7,385
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-24S4
|
$58,383
|
$1,751
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
TAS::75 0849::TAS ADMINISTRATIVE MODIFICATION
|
261200800001E
|
$313,286,406
|
$2,198
|
DMITROVSKY, ETHAN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Targeting KSHV malignancies and persistent infection
|
7R01CA197153-05
|
$357,994
|
$357,994
|
GAO, SHOU-JIANG
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Targeting KSHV malignancies and persistent infection
|
5R01CA197153-04
|
$19,444
|
$19,444
|
GAO, SHOU-JIANG
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Targeted Therapies for HIV-Associated Kaposi Sarcoma and Lymphoma
|
5R01CA163217-08
|
$342,759
|
$171,380
|
DITTMER, DIRK
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Support for 2018 International Conferences on EBV & KSHV and DNA Tumor Viruses
|
1R13CA232440-01
|
$4,000
|
$1,000
|
MERTZ, JANET
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$659,879
|
$593,891
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Studies on drug resistance in HIV-related Kaposi's sarcoma
|
ZIA BC 011730
|
$73,101
|
$73,101
|
Gottesman, Michael
|
CCR (NCI)
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-17
|
$384,750
|
$384,750
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
SPORE in Lymphoma
|
5P50CA126752-12
|
$2,297,796
|
$275,736
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
Spatiotemporal Gene Regulation and KSHV Replication
|
1R01CA225266-01A1
|
$359,138
|
$359,138
|
IZUMIYA, YOSHIHIRO
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Role of KSHV Viral Proteins in Signaling and Pathogenesis
|
2R01CA096500-16
|
$314,888
|
$314,888
|
DAMANIA, BLOSSOM
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Role of B cells in murine gammaherpesvirus 68
|
5R01CA095318-14
|
$368,305
|
$368,305
|
SPECK, SAMUEL
|
EMORY UNIVERSITY
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-22
|
$727,306
|
$727,306
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Regulation of EBV Latency by EBNA1
|
2R01CA093606-16
|
$380,903
|
$380,903
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Regional Oncology Research Center
|
3P30CA006973-55S1
|
$59,984
|
$1,200
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
3P30CA006973-55S2
|
$199,060
|
$3,981
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Regional Oncology Research Center
|
5P30CA006973-55
|
$7,069,034
|
$141,381
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Rational Translation of EZH2 Targeted Therapy in Germinal Center B-cell Lymphoma
|
5K08CA219473-02
|
$170,914
|
$51,274
|
ROTH, LISA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Precision Antibody-Based Therapy to Neutralize Epstein-Barr Virus-Associated PTLDs
|
1R21CA232275-01
|
$225,765
|
$225,765
|
OGEMBO, JAVIER
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Post-transcriptional Gene Regulation by EBV SM Protein.
|
2R01CA081133-16A1
|
$289,116
|
$289,116
|
SWAMINATHAN, SANKAR
|
UNIVERSITY OF UTAH
|
Total relevant funding to Herpes - Other for this search: $43,876,725
|